ATAT1 and Alzheimer disease: Interestingly, inhibition of ATAT1 expression by depletion of the epigenetic modifier METTL3 resulted in alleviated AD symptoms in a disease mouse model by reducing α-tubulin acetylation and enhancing brain migration of monocyte-derived macrophages involved in Aβ plaque clearance [58].